Prot #X052131/CL3-78989-006: A RandomizEd, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of GevokizUmAb in the TReatment of Subjects with Non-infectious IntermeDiate, Posterior, or Pan- uveitis Currently Controlled with Systemic Treat

Project: Research project

Project Details

StatusFinished
Effective start/end date1/29/13 → 1/29/16

Funding

  • JANIX BioSciences, LLC (Prot #X052131/CL3-78989-006)
  • XOMA Corporation (Prot #X052131/CL3-78989-006)